Search results
Company profile page for Alfasigma SpA including stock price, company news, executives, board members, and contact information.
8 lis 2023 · BOLOGNA, Italy, November 08, 2023 -- (BUSINESS WIRE)--Alfasigma S.p.A. ("Alfasigma") announced today that it has, through its wholly owned subsidiary Interstellar Acquisition Inc. ("Interstellar"),...
8 lis 2023 · Alfasigma S.p.A. (“Alfasigma”) announced today that it has, through its wholly owned subsidiary Interstellar Acquisition Inc. (“Interstellar”), successfully completed its tender offer to purchase all outstanding shares of common stock of Intercept Pharmaceuticals, Inc.
Pharmaceuticals. with passion. Contract manufacturing. Alfasigma Launches Morpho: New Brand Identity of the CDMO Business Unit Revealed at CPHI 2024. Alfasigma today unveiled Morpho, the new brand identity of its Contract Development and Manufacturing Organization (CDMO) Business Unit.
26 wrz 2023 · Under the terms of the merger agreement, Alfasigma has agreed to commence a cash tender offer to acquire all issued and outstanding shares of Intercept common stock for US$19.00 per share in...
26 wrz 2023 · Intercept Pharmaceuticals (ICPT) to be acquired by Alfasigma in an $800M deal, offering a premium to its IPO price. Read why this deal is good for Alfasigma.
8 lis 2023 · Stefano Golinelli, Chairman of Alfasigma, commented: “At Alfasigma, the passion we have for Pharmaceuticals is in our DNA - and a driver for our ambitious international growth plans. Thus, we are delighted to announce the successful outcome of our tender offer for Intercept Pharmaceuticals, Inc.
